Skye Bioscience Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Skye Bioscience's estimated annual revenue is currently $1.2M per year.(i)
  • Skye Bioscience's estimated revenue per employee is $77,500

Employee Data

  • Skye Bioscience has 16 Employees.(i)
  • Skye Bioscience grew their employee count by -6% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Skye Bioscience?

Skye Bioscience (OTC: SKYE) is a pharmaceutical company unlocking the potential of cannabinoids through the development of its proprietary cannabinoid derivatives to treat diseases with significant unmet needs. The Company's lead program, SBI-100 OE, is focused on developing a treatment for glaucoma, the world's leading cause of irreversible blindness.

keywords:N/A

N/A

Total Funding

16

Number of Employees

$1.2M

Revenue (est)

-6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.4M16N/AN/A
#2
$1.4M16N/AN/A
#3
$1.4M16N/AN/A
#4
$1.2M16-48%$22.9M
#5
$1.4M167%N/A